Revolution Medicines $345 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Hayward Holdings $214 million secondary offering
The stock is listed on the NYSE
Alight $476 million secondary offering
The stock is listed on the NYSE
Ardelyx $150 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Restaurant Brands International $142 million forward sale agreement
The forward sale agreement consists of 2,213,852 common shares
Mirion Technologies $150 million registered direct offering
We advised Mirion on the offering
CStone Pharmaceuticals HK$392.9 million placing of new shares
We advised CStone Pharmaceuticals on the placement
Sun Country Airlines $103.69 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Pepkor Holdings ZAR 4.9 billion secondary offering
The accelerated bookbuild transaction represented approximately 7.2% of Pepkor’s issued share capital
CureVac $250 million follow-on offering
We advised CureVac on the equity offering